Rhuematology Team - Monthly Report
Representative
*
Please Select
Felicia Nebel
Celeste Britz
Gauteng Vacant
Report Month
*
Please Select
May 2013
June 2013
July 2013
August 2013
September 2013
October 2013
November 2013
December 2013
January '14
February '14
March '14
April '14
May '14
June '14
July '14
August '14
September '14
October '14
November '14
December '14
Snap shot of YTD Performance vs. Prior year
*
Rows
EU TARGET: Cycle
EU ACTUAL: cycle
Growth (-or+)
MabThera total
Actemra total
Top 5 Declining Practices
No. 1 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
Rows
EU YTD 2012
EU YTD 2013
Growth vs. Previous year
MabThera
Actemra
Action Plan
*
No. 2 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
Rows
EU YTD 2012
EU YTD 2013
Growth vs. Previous year
MabThera
Actemra
Action Plan
*
No. 3 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
Rows
EU YTD 2012
EU YTD 2013
Growth vs. Previous year
MabThera
Actemra
Action Plan
*
No. 4 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
Rows
EU YTD 2012
EU YTD 2013
Growth vs. Previous year
MabThera
Actemra
Action Plan
*
No. 5 Declining Practice
Customer(s)
*
Latest Market Shares and Growth
*
Rows
EU YTD 2012
EU YTD 2013
Growth vs. Previous year
MabThera
Actemra
Action Plan
*
Monthly Activities
KEY CAMPAIGNS COMPLETED
*
Monthly representative Spend
PRODUCT PROMOTION
*
MabThera Spend
Actemra Spend
Total: Â
0
/Â
2600
Â
Competitor Intelligence
Humira
*
Enbrel
*
Orencia
*
Revellex
*
CRM & CHRIS compliance
Roche Systems
*
Rows
Completed
Not completed
CHRIS - comments input
1
2
CHRIS - manager discussion
3
4
CRM - synchronisation before 08:00
5
6
Territory Plan Updated
7
8
Signature
*
Submit
Should be Empty: